US 7033771
Use of insulin response modulators in the treatment of diabetes and insulin resistance
expired A61KA61K2039/505A61K38/1709
Quick answer
US patent 7033771 (Use of insulin response modulators in the treatment of diabetes and insulin resistance) held by Takeda Pharmaceutical Company Limited expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K38/1709